Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7344 pp409-414
9 April 2005

This section
Reprint   Photocopy

PDF 440K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

409 Pharmaceutical public health guidance launched New guidance on how pharmacists can improve the health of the public was published by the Department of Health last week ...more

409 Guidance for consultant posts announced Guidance for the development of consultant pharmacist posts in hospitals and primary care trusts in England was published by the Department of Health last week ...more

409 Scottish Executive will not amend zero discount list The Scottish Executive will not be amending the list of drugs subject to zero discount following the revised discount terms announced by GlaxoSmithKline and IVAX, it emerged this week ...more

409 New pharmacy contract launched by Reid Secretary of State for Health John Reid visited Warwick Pharmacy in London on 1 April to launch the new community pharmacy contract ...more

410 More contract details announced The Pharmaceutical Services Directions 2005 for advanced and enhanced services in England were published last week, giving an indication of what services pharmacies will be able to offer under the enhanced services tier of the new community pharmacy contract ...more

410 All over 65s to be offered pneumococcal immunisation Immunisation against pneumococcal infection is to be offered to everybody in England and Wales aged 65 years and over, the Department of Health and the Welsh Assembly Government have announced ...more

410 PCTs take responsibility for prison pharmacy Responsibility for commissioning health services in prisons in England is being transferred to primary care trusts a year ahead of schedule ...more

410 MHRA lacks discipline and leadership, says Health Select Committee Tighter controls on the promotion of new drugs and an urgent review of the Medicines and Healthcare products Regulatory Agency have been called for by the House of Commons Health Select Committee ...more

410 Funding for osteoporosis The Department of Health has announced £20m extra funding for osteoporosis service improvements and dual energy x-ray absorptiometry (DXA) scanners ...more

410 Let PCTs buy oxygen headsets The Pharmaceutical Services Negotiating Committee recommends that contractors do not buy new headsets for oxygen patients and that they ask their primary care trust to provide them ...more

411 Pilot sites will address racism in mental health care Seventeen pilot sites across England will pioneer best practice in eliminating racial discrimination in mental health services, the Department of Health announced last week ...more

411 DTB claims that simvastatin reclassification was flawed The way in which simvastatin became an over-the-counter medicine was “flawed” and represents a “poor model” for future POM to P switches, according to Drug and Therapeutics Bulletin ...more

411 APPG seeks details of how health policies of the main political parties will affect pharmacy Details of the three main political parties’ policies in relation to pharmacy are being sought by the All-Party Pharmacy Group ...more

411 Long-term care consultation Draft regulations on commissioning NHS long-term care were issued for consultation by the Department of Health this week ...more

411 Instalment dispensing Diazepam will be added to the products that GPs in England can order to be dispensed in instalments on NHS prescriptions from 14 April ...more

412 Gram-negative bacteria danger is being ignored The threat of multidrug-resistant Gram-negative bacteria is being overshadowed by the focus on Gram-positive infections such as methicillin-resistant Staphylococcus aureus, latest UK figures suggest. And microbiologists are warning that although there are a number of useful antibiotics for Gram-positive bacteria, either recently licensed or in development, there is little on the horizon to cope with multidrug-resistant Gram-negative bacteria ...more

412 Routine use of vitamins and minerals in elderly patients not supported by evidence There is insufficient evidence to support the routine use of multivitamin and mineral supplements to reduce infections in elderly people but further research is warranted, a new study shows ...more

412 Community pharmacy set to improve men’s health in Fife Community pharmacy will play a key role in a project to be launched next week that aims to improve men’s health ...more

412 MeReC updates HRT advice Evidence points to an overall net harm for use of hormone replacement therapy in chronic disease prevention, MeReC Bulletin advises ...more

412 Diuretics first line Diuretics should be used first line for both black and non-black patients with high blood pressure, data from the ALLHAT study show ...more

413 Six conditions responsible for 90pc of child deaths Almost 90 per cent of all deaths among children under five years of age are attributable to just six conditions, according to the World Health Organization, which published its annual World Health Report this week ...more

413 Guidance on access to drugs in developing countries issued Guidance for pharmaceutical companies on how they can increase access to essential medicines in developing countries was issued by the Department for International Development last week ...more

413 Medicines trade balance slips Britain’s trade surplus in pharmaceuticals fell by 5.5 per cent to £3.4bn last year ...more

413 DOTS can reduce transmission and incidence of drug-resistant TB A strategy that includes a short course of directly-observed therapy (DOTS) can rapidly reduce the transmission and incidence of both drug-susceptible and drug-resistant tuberculosis in settings with moderate rates of multidrug-resistant TB, according to research published this week ...more

414 New commission to replace CSM On 30 October, the Commission on Human Medicines will replace the Committee on Safety of Medicines and the Medicines Commission ...more

414 Pharmaceutical industry responds slowly to NHS The pharmaceutical industry is responding too slowly to changes in the health service to meet the needs of today’s NHS, the results of a study suggest ...more

414 Ranbaxy settles price fixing claim with the Department of Health Ranbaxy, one of the generics companies being sued by the Department of Health over allegations of price fixing and overcharging, has reached an out-of-court settlement with the Government ...more

414 Roche falls foul of ABPI code Roche recently breached the Association of the British Pharmaceutical Industry’s code of practice by promoting Xenical (orlistat) direct to more than 14,000 patients ...more

414 Food supplement law in doubt An advocate general of the European Court has said that a European Directive that restricts the availability of food supplements is invalid because it does not reflect legal principles of fairness and sound administration ...more

414 Co-op sales up United Co-op Healthcare has announced a 9 per cent rise in sales, to £131m, for the financial year ending on 22 January ...more

414 NHS learning budget The NHS Institute for Learning, Skills and Innovation will have a budget of £80m for 2005–06, as well as £20m for transition costs ...more


R&D news

415 MAO-B inhibitor shows promise in parkinsonism Rasagiline, a new monoamine oxidase B inhibitor, is an effective adjunctive treatment for Parkinson’s disease and can improve symptoms associated with levodopa treatment, an 18-week trial has shown ...more

415 Diabetes gene identification could lead to new therapy A gene that appears to play a critical role in the development of type 1 diabetes has been identified by researchers at the North Shore-Long Island Health System in Manhasset, New York ...more

415 Place for cannabinoid compounds in cardiovascular disease Drugs that affect cannabinoid receptors might have a place in the management of cardiovascular disease, results from two recent studies reveal ...more

415 Overactive bladder treatments show differences in efficacy Differences between antimuscarinic treatments for overactive bladder syndrome are beginning to emerge ...more

415 Cranberries for vascular function Using a model of hypercholesterolaemia researchers have shown that cranberry juice can improve vascular function and may protect against heart disease ...more

Back to Top


©The Pharmaceutical Journal